Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease
Wim Wuyts(KU Leuven), Elisabeth Bendstrup(Aarhus University Hospital), Demosthenes Bouros(Democritus University of Thrace), Paul Bresser(Amsterdam UMC Location University of Amsterdam), Benjamin Bondue, Marlies Wijsenbeek(Erasmus University Rotterdam), Ole Hilberg(University of Southern Denmark), Spyridon Papiris(National and Kapodistrian University of Athens), António Morais(Universidade do Porto), Effrosyni D. Manali(Inserm), Jesper Magnusson(Sahlgrenska University Hospital), Carlos Robalo Cordeiro(Imperial College London), Saher Burhan Shaker(Gentofte Hospital), Marcel Veltkamp(University Medical Center Utrecht)
Cited by 93
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Antifungal lactic acid bacteria as biopreservatives
|Trends in Food Science & Technology|2005|685
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579